Clinical Trial

Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
This is a study that aims to demonstrate the non-inferiority of minimally invasive surgery versus open surgery, as an approach for patients with advanced ovarian cancer who received neoadjuvant chemotherapy, giving them the benefits of laparoscopic surgery. This way they can continue with their complementary treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-12.
Trial Details
NCT Number NCT06883409
Lead Sponsor Instituto Nacional de Cancerologia de Mexico
Conditions Ovarian Neoplasms
Enrollment 33 participants
Start Date 2022-05-19
Primary Completion 2024-06-14 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-26